CNS & Pain

BioDuro offers a broad portfolio of validated in vivo disease models supporting efficacy studies across neurodegenerative, neurological, inflammatory, and pain-related disorders.

Our team works closely with clients to select the most appropriate models based on therapeutic targets, disease biology, and study objectives.

In Vivo Disease Models

Our validated in vivo disease models support the evaluation of therapeutic candidates across a broad range of CNS and pain indications. From neurodegenerative and neurological disorders to neuroinflammation and pain, BioDuro provides the models and expertise to support every stage of preclinical research.

Neurodegenerative Disease Models

Evaluate therapies targeting progressive neurodegenerative disorders.

Parkinson’s disease
  • MPTP acute model
  • MPTP chronic model
  • 6-OHDA model
Alzheimer’s disease
  • 5xFAD transgenic mouse model
Amyotrophic Lateral Sclerosis (ALS)
  • SOD1-G93A mouse model

Neurological Disease Models

Established models for studying a broad range of neurological disorders.

Stroke
  • Transient middle cerebral artery occlusion (tMCAO) model
Epilepsy
  • PTZ-induced epilepsy model
Perioperative Neurocognitive Disorder (PND)
Sleep Disorders
  • Sleep deprivation model
  • Caffeine-induced sleep disturbance model

Neuroinflammation & Related Models

Models used to investigate neuroinflammation and other CNS disorders.

Neuroinflammation
  • LPS-induced neuroinflammation
Hepatic Encephalopathy
  • Thioacetamide-induced hepatic encephalopathy
NMDA Receptor Dysfunction
  • MK801 model
Respiratory Depression
  • Morphine-induced respiratory depression

Pain Models

BioDuro offers a broad portfolio of validated in vivo pain models to support efficacy studies across acute, inflammatory, neuropathic, and chronic pain indications.

  • Formalin pain model
  • Adjuvant pain model
  • MIA pain model
  • Chemotherapy-induced pain model
  • Diabetic pain model
  • Carrageenan pain model
  • Chronic constriction injury (CCI) model

Validated Disease Models

A broad portfolio of established in vivo models spanning neurodegenerative, neurological, neuroinflammatory, and pain-related disorders.

Customized Study Design

Study designs tailored to therapeutic targets, disease biology, and program objectives.

Comprehensive Endpoints

Assessment of efficacy using disease-relevant behavioral, functional, and translational endpoints.

Experienced Scientific Support

Close collaboration with experienced scientists from study planning through data interpretation.